FDA Approved: MYCOPHENOLATE MOFETIL — Original Application (Ascend Laboratories, LLC)

View source ↗

Summary

FDA approved an original application for a generic version of mycophenolate mofetil from Ascend Laboratories, intended to prevent organ transplant rejection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Transplant Rejection
• Kidney Transplant Rejection
• Liver Transplant Rejection

Drugs mentioned

• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)

Snippet

ORIG AP for MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)